The Latest Cardiac and Vascular News
MASON, Ohio–(BUSINESS WIRE)– Genetesis, a medical device company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has closed an oversubscribed round of $7.5M in Series A financing. CincyTech led the round with participation from existing investors including Mark Cuban’s Radical Investments, and new investors including […]
Paris, France and Munich, Germany, June 4, 2018 – TRiCares SAS, a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is pleased to announce today the successful completion of a €22 Million ($25.4 Million) Series B financing round. Proceeds from the financing will be used to advance […]
VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that it has become a member of the Cardiac Safety Technical Committee of the Health and Environmental Sciences Institute (HESI), an industry-led, international consortium including major pharmaceutical and […]
PARIS, May 31, 2018 /PRNewswire/ — Nobles Medical Technologies II, Inc. (NMT 2) today announced that following a highly successful showing at EuroPCR of the NobleStitch, the company will accelerate its sales, marketing and proctoring efforts to meet the increased demand in both existing countries and new territories. The company noted receiving un-paralleled […]
CAESAREA, Israel and TAMPA, Fla., May 31, 2018 /PRNewswire/ — Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection for patients undergoing cardiac procedures, today announced the launch of Phase II of the REFLECT trial to evaluate the safety and efficacy of the next generation of Keystone Heart […]
BURLINGAME, Calif.–(BUSINESS WIRE)– JC Medical, Inc. announced the treatment of the first patient with the company’s Transfemoral TAVI device, the J-Valve TF System for aortic regurgitation. The first patient was treated at St. Paul’s Hospital – Vancouver, Canada by John Webb, MD, FACC, FSCAI, Director of Interventional Cardiology. There are currently […]
TEL AVIV, ISRAEL, May 30, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS), thrombus management technologies and neurovascular devices, today announced that Professor Piotr Musiałek, from the Department of Cardiac and Vascular Diseases, John Paul II Hospital, Kraków, Poland, presented the expanded 24 month […]
NEW YORK, May 30, 2018 /PRNewswire/ — TARA Biosystems Inc., a company offering physiologically relevant, human “heart-on-a-chip” tissue-models for drug discovery and development applications, is proud to announce that TARA CEO Dr. Misti Ushio has been recognized by Fast Company as one of the Top 100 Most Creative People in Business today. The annual list honors an […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the closing of an initial tranche of $17.8 million in a financing round expected to reach $30 million, led by Savitr Capital and other existing investors. Ancora Heart’s AccuCinch® Ventricular Repair System is […]
• Diab8 is a 55-center, 3.040-patient randomized controlled trial that pits the performance of Cre8™ EVO, a Polymer-free Amphilimus-eluting stent, against the Everolimus-Eluting stents in the treatment of coronary artery disease in diabetic patients • The Diab8 study is designed to establish the superior efficacy of the Cre8™ EVO, the […]
